Clinical Trials Directory

Trials / Completed

CompletedNCT01173796

Ablation of Perimitral Flutter Following Catheter Ablation of Atrial Fibrillation: Impact on Outcomes

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
44 (actual)
Sponsor
Texas Cardiac Arrhythmia Research Foundation · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This prospective, randomized study aims to compare the impact of ablation of perimitral flutter only versus cardioversion and repeat isolation of pulmonary veins with ablation of additional triggers, on procedure outcome.

Detailed description

Background: In recent years, catheter ablation has been accepted as the treatment-of-choice for drug-refractory atrial fibrillation (AF). It is centered around isolating pulmonary veins (PVs) and its success rate in curing AF is very high (56%-85%) (1). However, despite isolation of this dominant source of triggers, recurrent tachyarrhythmia is the major complication of this procedure with peri-mitral atrial flutter (PMFL) being the most common macro-reentrant arrhythmia in context of AF ablation (2). These often drug-refractory arrhythmias are frequently associated with more severe symptoms than the original AF (3) and warrant the necessity for redo-ablation. This study aims to compare the impact of two different redo-ablation strategies on the procedure outcome; (1) ablation of the perimitral flutter only and (2) cardioversion and repeat isolation of pulmonary veins (PV) with ablation of additional triggers. Study method: A total number of 65 AF patients presenting for redo-ablation and PMFL will be randomized to perimitral flutter ablation only or cardioversion and re-isolation (PVI) plus ablation of additional triggers. Additional triggers will be identified with the help of post-ablation drug provocation with isoproterenol. Patients will enter a follow-up period of 12 months after the ablation procedure, when they will be monitored for recurrence of arrhythmia detected either by in-clinic or remote device interrogation at 1, 3, 6 and 12 month post-procedure.

Conditions

Interventions

TypeNameDescription
PROCEDUREcatheter ablationperimitral flutter ablation by blocking the mitral isthmus
PROCEDUREcatheter ablationcardioversion and repeat isolation of pulmonary veins (PV) with ablation of additional triggers

Timeline

Start date
2010-03-01
Primary completion
2011-09-01
Completion
2011-09-01
First posted
2010-08-02
Last updated
2012-07-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01173796. Inclusion in this directory is not an endorsement.